Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2011

  1. Estudio OASIS: Manejo terapéutico de la acromegalia en un escenario de práctica clínica habitual. Evaluación de la eficacia de las diversas estrategias de tratamiento aplicadas

    Endocrinologia y Nutricion, Vol. 58, Núm. 9, pp. 478-486

  2. Somatotroph tumor progression during pegvisomant therapy: A clinical and molecular study

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 2

2010

  1. Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 5, pp. 2147-2154

  2. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229

2009

  1. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: Influence of obesity and smoking

    European Journal of Endocrinology, Vol. 160, Núm. 3, pp. 469-480

  2. Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome

    Fertility and Sterility, Vol. 91, Núm. 6, pp. 2527-2536

2007

  1. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome

    Human Reproduction, Vol. 22, Núm. 12, pp. 3197-3203

  2. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 6, pp. 2141-2148